Table 3 Demographic and clinical characteristics of the 77 PCP patients according to herpesvirus detection

Mean age ± SD (years)

60.9 +/- 15.5

58.9 +/- 13.5

0.59^*

Male sex, n (%)

14 (60.9)

36 (66.7)

0.90^**

Underlying disease, n (%)

Hematological malignancy

11 (47.8)

26 (48.1)

0.97^**

Solid organ or hematopoietic stem cell transplant

11 (47.8)

15 (27.8)

0.08^**

Solid tumor

5 (21.7)

9 (16.7)

0.83^**

Autoimmune disease

1 (4.3)

8 (14.8)

0.35^**

Lung disease

1 (4.3)

6 (11.1)

0.60^**

HIV infection

0 (0)

5 (9.3)

0.31^**

Comorbidity, n (%)

Cardiovascular disease

10 (43.5)

22 (40.7)

0.82^**

Diabetes

4 (17.4)

9 (16.6)

1^**

Renal failure

4 (17.4)

5 (9.2)

0.52^**

Immunosuppressive treatment, n (%)

Corticosteroids

7 (30.4)

15 (27.7)

0.81^**

Cytotoxic chemotherapy

8 (34.8)

15 (27.7)

0.53^**

Antiviral treatment, n (%)

6 (26)

18 (33.3)

0.04^**